您的当前位置：首页 > 行业数据 > 中国已获批主要自免疾病的小分子靶向药和生物制剂（不含生物类似物及仿制药）

中国已获批主要自免疾病的小分子靶向药和生物制剂（不含生物类似物及仿制药）

行业数据

下载图片

原图定位

同报告图片

/ 4

中国已获批主要自免疾病的小分子靶向药和生物制剂（不含生物类似物及仿制药）_第1页

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

中国已获批主要自免疾病的小分子靶向药和生物制剂（不含生物类似物及仿制药）_第2页

中国已获批主要自免疾病的小分子靶向药和生物制剂（不含生物类似物及仿制药）_第3页

中国已获批主要自免疾病的小分子靶向药和生物制剂（不含生物类似物及仿制药）_第4页

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